Cargando…

PI3K Signaling in B Cell and T Cell Biology

Detalles Bibliográficos
Autores principales:	Okkenhaug, Klaus, Turner, Martin, Gold, Michael R.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2014
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4217509/ https://www.ncbi.nlm.nih.gov/pubmed/25404931 http://dx.doi.org/10.3389/fimmu.2014.00557

Ejemplares similares

PI3K in T Cell Adhesion and Trafficking
por: Johansen, Kristoffer H., et al.
Publicado: (2021)

Does the PI3K pathway promote or antagonize regulatory T cell development and function?
por: Soond, Dalya R., et al.
Publicado: (2012)

PI3K Signaling in Normal B Cells and Chronic Lymphocytic Leukemia (CLL)
por: Okkenhaug, Klaus, et al.
Publicado: (2015)

PI3K induces B-cell development and regulates B cell identity
por: Abdelrasoul, Hend, et al.
Publicado: (2018)

PI3Kδ Forms Distinct Multiprotein Complexes at the TCR Signalosome in Naïve and Differentiated CD4(+) T Cells
por: Luff, Daisy H., et al.
Publicado: (2021)

Editorial: Lipid Signaling in T Cell Development and Function
por: Sauer, Karsten, et al.
Publicado: (2015)

Recent Advances in Lupus B Cell Biology: PI3K, IFNγ, and Chromatin
por: Bacalao, Maria A., et al.
Publicado: (2021)

Antigen receptor signalling: a distinctive role for the p110δ isoform of PI3K
por: Okkenhaug, Klaus, et al.
Publicado: (2007)

Editorial: Human Disorders of PI3K Biology
por: Lucas, Carrie L., et al.
Publicado: (2020)

PI3Kδ promotes CD4(+) T-cell interactions with antigen-presenting cells by increasing LFA-1 binding to ICAM-1
por: Garçon, Fabien, et al.
Publicado: (2016)

PI3K Signaling in Dendritic Cells Aggravates DSS-Induced Colitis
por: Kuttke, Mario, et al.
Publicado: (2022)

The Therapeutic Potential for PI3K Inhibitors in Autoimmune Rheumatic Diseases
por: Banham-Hall, Edward, et al.
Publicado: (2012)

The Role of the PI3K Signaling Pathway in CD4(+) T Cell Differentiation and Function
por: Han, Jonathan M., et al.
Publicado: (2012)

Role of PI3K/Akt signaling in memory CD8 T cell differentiation
por: Kim, Eui Ho, et al.
Publicado: (2013)

PI3K inhibitors in inflammation, autoimmunity and cancer
por: Stark, Anne-Katrien, et al.
Publicado: (2015)

Extracellular Vesicles Mediate Mesenchymal Stromal Cell-Dependent Regulation of B Cell PI3K-AKT Signaling Pathway and Actin Cytoskeleton
por: Adamo, Annalisa, et al.
Publicado: (2019)

The PI3K p110δ Regulates Expression of CD38 on Regulatory T Cells
por: Patton, Daniel T., et al.
Publicado: (2011)

Immunometabolism and PI(3)K Signaling As a Link between IL-2, Foxp3 Expression, and Suppressor Function in Regulatory T Cells
por: Fan, Martin Y., et al.
Publicado: (2018)

The PI3K∂-Selective Inhibitor Idelalisib Induces T- and NK-Cell Dysfunction Independently of B-Cell Malignancy-Associated Immunosuppression
por: Rohrbacher, Lisa, et al.
Publicado: (2021)

PI3Kγ Regulatory Protein p84 Determines Mast Cell Sensitivity to Ras Inhibition—Moving Towards Cell Specific PI3K Targeting?
por: Jin, Julie R., et al.
Publicado: (2020)

BCAP Regulates Dendritic Cell Maturation Through the Dual-Regulation of NF-κB and PI3K/AKT Signaling During Infection
por: Miao, Yuhui, et al.
Publicado: (2020)

PI3Kδ Regulates the Magnitude of CD8(+) T Cell Responses after Challenge with Listeria monocytogenes
por: Pearce, Verity Q., et al.
Publicado: (2015)

Enhanced AKT Phosphorylation of Circulating B Cells in Patients With Activated PI3Kδ Syndrome
por: Asano, Takaki, et al.
Publicado: (2018)

RNA-binding proteins as a point of convergence of the PI3K and p38 MAPK pathways
por: Venigalla, Ram K. C., et al.
Publicado: (2012)

Resistance Mutations to BTK Inhibitors Originate From the NF-κB but Not From the PI3K-RAS-MAPK Arm of the B Cell Receptor Signaling Pathway
por: Smith, C. I. Edvard, et al.
Publicado: (2021)

AKTivation of PI3K/AKT/mTOR signaling pathway by KSHV
por: Bhatt, Aadra P., et al.
Publicado: (2013)

Dysregulated PI3K Signaling in B Cells of CVID Patients
por: Harder, Ina, et al.
Publicado: (2022)

Inactivation of the PI3K p110δ breaks regulatory T cell-mediated immune tolerance to cancer
por: Ali, Khaled, et al.
Publicado: (2014)

B7-H3 promoted proliferation of mouse spermatogonial stem cells via the PI3K signaling pathway
por: Wei, Xuedong, et al.
Publicado: (2017)

Selective inhibitors of phosphoinositide 3-kinase delta: modulators of B-cell function with potential for treating autoimmune inflammatory diseases and B-cell malignancies
por: Puri, Kamal D., et al.
Publicado: (2012)

The Isoform Selective Roles of PI3Ks in Dendritic Cell Biology and Function
por: Aksoy, Ezra, et al.
Publicado: (2018)

Strategies to Overcome Failures in T-Cell Immunotherapies by Targeting PI3K-δ and –γ
por: Chandrasekaran, Sanjay, et al.
Publicado: (2021)

The c-Myc/miR17-92/PTEN Axis Tunes PI3K Activity to Control Expression of Recombination Activating Genes in Early B Cell Development
por: Benhamou, David, et al.
Publicado: (2018)

An Emerging Role for PI5P in T Cell Biology
por: Nunès, Jacques A., et al.
Publicado: (2013)

PI3Kδ Inhibition Enhances the Antitumor Fitness of Adoptively Transferred CD8(+) T Cells
por: Bowers, Jacob S., et al.
Publicado: (2017)

The Treatment of Activated PI3Kδ Syndrome
por: Coulter, Tanya I., et al.
Publicado: (2018)

Regulation of PI-3-Kinase and Akt Signaling in T Lymphocytes and Other Cells by TNFR Family Molecules
por: So, Takanori, et al.
Publicado: (2013)

Human B Cells Engage the NCK/PI3K/RAC1 Axis to Internalize Large Particles via the IgM-BCR
por: Verstegen, Niels J. M., et al.
Publicado: (2019)

The Inhibitory Receptor CLEC12A Regulates PI3K-Akt Signaling to Inhibit Neutrophil Activation and Cytokine Release
por: Paré, Guillaume, et al.
Publicado: (2021)

ACSL1 Inhibits ALV-J Replication by IFN-Ⅰ Signaling and PI3K/Akt Pathway
por: Zhang, Qihong, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_siilgav59ovc3ggvgm3akgkm5o